Cargando…
Signatures Beyond Oncogenic Mutations in Cell-Free DNA Sequencing for Non-Invasive, Early Detection of Cancer
Early detection of cancer saves lives, but an effective detection strategy in public health settings requires a delicate balance - periodic screening should neither miss rapidly progressing disease nor fail to detect rare tumors at unusual locations; on the other hand, even a modest false positive r...
Autor principal: | De, Subhajyoti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551553/ https://www.ncbi.nlm.nih.gov/pubmed/34721546 http://dx.doi.org/10.3389/fgene.2021.759832 |
Ejemplares similares
-
The Non-Coding Oncogene: A Case of Missing DNA Evidence?
por: Shahrouki, Puja, et al.
Publicado: (2012) -
Moving Beyond DNA Sequence to Improve Plant Stress Responses
por: Saeed, Faisal, et al.
Publicado: (2022) -
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer
por: Stasik, Sebastian, et al.
Publicado: (2022) -
Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis
por: Palmieri, Maria, et al.
Publicado: (2022) -
Characteristics of mutational signatures of unknown etiology
por: Hu, Xiaoju, et al.
Publicado: (2020)